by John Warren | Jul 22, 2024
The Centers for Medicare & Medicaid Services (CMS) recently unveiled a proposal in the 2025 Medicare Physician Fee Schedule to cover Digital Mental Health Treatment (DMHT) devices. This policy marks a significant step towards integrating digital health...
by John Warren | Apr 16, 2024
In their FY 2025 Inpatient Prospective Payment System proposed rule, CMS proposes a policy that would increase Medicare payment for gene therapy targeting sickle cell disease. CMS asserts that these additional New Technology Add-on Payments would increase access to...
by John Warren | Apr 15, 2024
As a part of the CMS FY 2025 Inpatient Prospective Payment System proposed rule, CMS followed up on its promise from last year to propose policies that would help the hospital industry to maintain access to essential medicines. But could this Medicare Essential...
by John Warren | Feb 15, 2024
Last April, the Centers for Medicare & Medicaid Services (CMS) released the 2024 Medicare Part D rule. CMS recently issued a list of frequently asked questions addressing parts of these Medicare Advantage coverage criteria and utilization management requirements...
by John Warren | Feb 5, 2024
Recently, an FDA reclassification process was announced that will reclassify many high-risk medical devices into the less burdensome “moderate risk” category. This includes certain infectious disease and companion diagnostic tests, allowing them to go...
